SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 12, 1998
Bio-Imaging Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware 1-11182 11-2872047
- --------------------------------------------------------------------------------
(State or Other (Commission File Number) (IRS Employer
Jurisdiction Identification No.)
of Incorporation)
830 Bear Tavern Road, West Trenton, New Jersey 08628-1020
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(609) 883-2000
--------------------------------
(Registrant's telephone
number, including area code)
------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant.
On January 12, 1998, Bio-Imaging Technologies, Inc. (the "Company")
selected Arthur Andersen LLP to act as independent accountants for the Company
and informed the prior auditors, Goldstein, Golub, Kessler & Company, P.C., of
its decision. In connection with its audits for each of the two years in the
period ended September 30, 1997 and thereafter, there were no disagreements with
the prior auditors on any matters of accounting principles or practices,
financial statement disclosure, or auditing scope or procedures. The prior
auditors' report on the Company's financial statements for each of the two years
in the period ended September 30, 1997 contained no adverse opinion or
disclaimer of opinion and was not modified or qualified as to uncertainty, audit
scope, or accounting principles. The decision to change accountants was approved
by the Board of Directors of the Company. The prior auditors have furnished the
Company with a letter addressed to the Securities and Exchange Commission
stating their agreement with the above statements.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Information of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Exhibit No.
-----------
Description of Exhibit
----------------------
16 Letter re: Change in Certifying Accountants.
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Bio-Imaging Technologies, Inc.
By: /s/Robert J. Phillips
-----------------------------------
Robert J. Phillips, Vice President
and Chief Financial Officer
(Principal Financial and
Accounting Officer)
Date: January 15, 1998
Goldstein Golub Kessler & Company, P.C.
1185 Avenue of the Americas
New York, New York 10036-2602
January 14, 1998
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
Re: Bio-Imaging Technologies, Inc.
Commission File #1-11182
Gentlemen:
We have read the above referenced Registrant's response to Item 4 - Changes in
Registrant's Certifying Accountant with respect to its Current Report on Form
8-K dated January 13, 1998 and concur with the statements made therein.
Sincerely,
/s/Goldstein Golub Kessler & Company, P.C.
GOLDSTEIN GOLUB KESSLER & COMPANY, P.C.
